We are live on ! Find out more
LFSC

F/m Emerald Life Sciences Innovation ETF

3 hedge funds and large institutions have $50.2M invested in F/m Emerald Life Sciences Innovation ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

88.82% more ownership

Funds ownership: 2.31%91.13% (+89%)

9% more capital invested

Capital invested by funds: $46M → $50.2M (+$4.21M)

25% less funds holding

Funds holding: 43 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
1
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EMFAT
1
Emerald Mutual Fund Advisers Trust
Pennsylvania
$49.2M +$45.7M +1,997,035 New
HAIM
2
Hunter Associates Investment Management
Pennsylvania
$1M +$93.9K +4,101 +11%
UBS Group
3
UBS Group
Switzerland
$21K +$19.3K +845 +10,563%
MASUI
4
MIRAE ASSET SECURITIES (USA) INC.
New York
-$298K -13,252 Closed
PFBT
5
Parkside Financial Bank & Trust
Missouri
-$27.3K -1,215 Closed

LFSC Hedge Fund Activity: Q2 2025 in Review

3 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in F/m Emerald Life Sciences Innovation ETF (LFSC) for Q2 2025, worth a combined $50.2M — up 9.2% from $46M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LFSC and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Emerald Mutual Fund Advisers Trust, opening a new position worth an estimated $45.7M. The largest seller was MIRAE ASSET SECURITIES (USA) INC., exiting entirely with an estimated $298K sold.

  • 3 institutional investors held F/m Emerald Life Sciences Innovation ETF (LFSC) as of Q2 2025, down from 4 in Q1 2025.
  • Funds reported $50.2M of F/m Emerald Life Sciences Innovation ETF stock for Q2 2025, up 9.2% quarter-over-quarter.
  • 1 fund opened new F/m Emerald Life Sciences Innovation ETF positions in Q2 2025 and 2 closed out, a net change of -1 holder.
  • The largest F/m Emerald Life Sciences Innovation ETF buyer in Q2 2025 was Emerald Mutual Fund Advisers Trust, an estimated $45.7M added.
  • The largest F/m Emerald Life Sciences Innovation ETF seller in Q2 2025 was MIRAE ASSET SECURITIES (USA) INC., an estimated $298K sold.

Based on aggregated 13F filings for Q2 2025.